HWMA
SYRS

Heritage Wealth Management (Arizona)’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Heritage Wealth Management (Arizona)’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$129 Buy
36
+18
+100% +$78 ﹤0.01% 1065
2022
Q3 		$0 Buy
+18
New +$146 ﹤0.01% 1115

Other funds holding SYRS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Heritage Wealth Management (Arizona)'s SYRS Position: Q4 2022 in Review

Heritage Wealth Management (Arizona) increased its Syros Pharmaceuticals, Inc. Common Stock (SYRS) stake by 100% in Q4 2022, buying an estimated $78 and bringing the position to 36 shares worth $129. The position accounts for ﹤0.01% of the portfolio, ranked #1065.

Heritage Wealth Management (Arizona) first reported a position in SYRS in Q3 2022 and has held it in 2 quarters since. 57 funds tracked by Wall St. Rank hold SYRS as of Q4 2022.

  • Heritage Wealth Management (Arizona) held 36 shares of Syros Pharmaceuticals, Inc. Common Stock worth $129 as of Q4 2022.
  • Heritage Wealth Management (Arizona) bought 18 Syros Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $78.
  • Syros Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Heritage Wealth Management (Arizona)'s portfolio in Q4 2022, its #1065 holding.
  • Heritage Wealth Management (Arizona) first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2022 and has held it in 2 quarters since.
  • 57 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q4 2022, filed 13 Feb 2023.